Francesca Mordant

15PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsPacific Peoples cultural determinants of healthMedical infection agents (incl. prions)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 27, 2026
Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.

|Nov 24, 2025
Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial.

Keith J Chappell, Francesca L Mordant, Alberto A Amarilla

|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.

Wuji Zhang, Lukasz Kedzierski, Brendon Y Chua

|Apr 25, 2023
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release.

Larisa I Labzin, Keng Yih Chew, Kathrin Eschke

|Dec 01, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 months.

Francesca L Mordant, Olivia H Price, Rajeev Rudraraju

|Apr 24, 2021
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.

Phillip Pymm, Amy Adair, Li-Jin Chan

Pageof 3

Frequent Collaborators

8 joint publications

Kanta Subbarao

6 joint publications

Amy W Chung

6 joint publications

Stephen J Kent

6 joint publications

Adam K Wheatley